Impact of imaging systems on probability of clonality (1) · 2016-09-05 · Cell Line 8 28 Cell...
Transcript of Impact of imaging systems on probability of clonality (1) · 2016-09-05 · Cell Line 8 28 Cell...
The impact of using an imaging system to provide the regulatory evidence that a cell line has a high probability of being clonally derived George Hutchinson VP – Asia Pacific Region
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Content
1. Review of the global adoption of an imaging system based strategy for cloning
2. Overview of regulatory requirements 3. Review of cloning methods 4. FDA requirements for imaging systems 5. Performance of imaging systems 6. Imaging systems and workflow improvements
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
The view of the USFDA
• FDA 2014 “ Advances in technology (e.g. imaging) might allow for one round of cloning performed at an appropriate dilution
• Establishing Clonal Cell lines – Regulatory Perspective, Sarah Kennett PhD, Review Chief, Division of Monoclonal Antibodies, OBP/OPS/CDER/FDA, WCBP 2014
• FDA 2016 - “Considerations for commonly used cloning procedures – Single cells are plated and imaged from day 0 until the cell grows into
a colony. Supporting data should include a picture of the single cell and the entire well”
• Mitigating risk of lack of assurance of cell bank clonality on product lifecycle, Rashmi Rawat, Office of Biotechnology Products OPQ/CDER/FDA, Cell Line Development and Engineering Conference, 11-13 April 2016, Vienna, Austria拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Adoption of imaging systems
• Based on our market knowledge we estimate there are at least 95 biopharmaceutical companies currently using or evaluating an imaging based strategy – Of these at more than 60 are using the Cell Metric – Of those using the Cell Metric at least 25 have replaced and
existing imaging system with the Cell Metric • It is understood that very recently the FDA has approved
the first IND filing based on an imaging / one round of limiting dilution strategy
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Monoclonality is a regulatory requirement
• ICH Q5D – For recombinant products, the cell substrate is the transfected cell
containing the desired sequences, which has been cloned from a single progenitor
• (US)FDA points to consider in the characterization of cell lines used to produce biologics (1993) – The MCB is defined as a collection of cells of uniform composition derived
from a single tissue or cell • EMA/CHMP Guidance on development, production, characterization
and specifications for monoclonal antibodies and related products (2008) – The cell substrate to be used for the production of the monoclonal
antibodies should be a stable and continuous monoclonal cell line that has been developed by means of recombinant DNA and/or other suitable technologies 拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
• Since~ 2011/2012 the U.S. FDA has requested information about clonality at early IND filings:
– “Submit data to the IND that provides assurance that this method resulted in derivation of a single cell clone or provide information on how you will go about generating these data and the timeframe for submission of the information”
Regulatory and monoclonality for IND filings
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Where does the clonality of the MCB impact?
• Regulatory • Product quality • Product lifecycle • Manufacturing change • The overall Control Strategy
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Regulatory
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Product quality
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Impact of clonality on product life cycle
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Impact on product quality
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Impact on Control Strategy
Mitigating risk of lack of assurance of cell bank clonality on product lifecycle Rashmi Rawat, Office of Biotechnology Products OPQ/CDER/FDA
Cell Line Development and Engineering Conference, 11-13 April 2016, Vienna, Austria
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
The importance of clonality in Production
• Clonality is a regulatory requirement • Regulatory requirements for control strategy of
manufacturing changes to products derived from clonal cell banks are less stringent when compared to those for products derived from non-clonal banks
• Product quality is less variable • Easier to predict the risk associated with small
changes • Clonality impacts directly on product lifecycle拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Regulatory submissions
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
• One cannot demonstrate clonality, rather, one can use data to show that your cell line development methods can assure that your MCB has a high probability of being clonally derived – Regulatory Considerations in Establishing Clonality for Cell
lines expressing therapeutic proteins, Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Limiting dilution (LDC)
• Most commonly used cloning method – Typically use 2 rounds, seeding at 0.5 cells or less per well – Statistical analysis based upon work by Coller & Coller
(Hybridoma, 1983 2: 91-96) – Historically it has been necessary to demonstrate a probability
>96% to the USFDA • Statistical assumptions
– Cells are distributed according to a Poisson distribution – All cells have an equal chance of survival and growth
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Limiting Dilution - FDA view
Data from Kennett presentation WCBP 2014
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Limiting Dilutions - Realities
• Reality – outgrowth is significantly less than 100% – This example from BioCSL Australia
• For each of the 3 protein products, 7 sets of 4 x 96 well plates seeded with different cell lines at 0.5 cells per well
Average number of
colonies growing from
wells with single cells
Theoretical 116
Protein Product 1 18
Protein Product 2 23
Protein Product 3 24
Data source – The use of imaging to demonstrate clonality of production CHO Cell Lines – Experiences and learnings Presentation by Arna Andrews, Director, Cell Line Development, BioCSL Limited, Australia Informa Cell Line Development & Engineering Conference, April 11th 2016
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Limiting Dilutions (LDC) - Realities
• Cloning efficiency is dependent upon host cell line • Example - 4 x 96 well plates seeded at 0.5 cells per well
Protein Product
2
Colonies growing from
wells with single cells
Theoretical 116
Cell Line 8 28
Cell Line 9 7
Cell Line 10 33
Cell Line 11 16
Cell Line 12 22
Cell Line 13 15
Cell Line 14 40
Data source – The use of imaging to demonstrate clonality of production CHO Cell Lines – Experiences and learnings Presentation by Arna Andrews, Director, Cell Line Development, BioCSL Limited, Australia Informa Cell Line Development & Engineering Conference, April 11th 2016拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Limiting Dilution (LDC) - Realities
• Outgrowth is more likely in wells containing > 1 cell
Cell Line % outgrowth from
a well seeded
with a single cell
% outgrowth from
a well seeded
with more than
one cell
Theoretical 77% 23%
Momenta - A 46% 54%
Momenta - B 35% 65%
Momenta - C 40% 60%
BioCSL - 1 46% 54%
BioCSL - 2 54% 46%
BioCSL - 3 48% 52%
Data sources Efficient Screening Strategies to Address Monoclonality & Reduce Time Lines Chaomei He, Associate Director, Momenta Pharmaceuticals Inc. USA IBC 4th Annual Cell Line Development & Engineering Conference Asia The use of imaging to demonstrate clonality of production CHO Cell Lines – Experiences and learnings, Arna Andrews, Director, Cell Line Development, CSL Ltd. Australia Informa Cell Line Development 7 Engineering, Vienna April 2016拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Impact of outgrowth bias on Probability of Clonality
• Theory v Reality when seeding at 0.5 cells per well
Statistically derived
Probability of
clonality
Probability of clonality based on outgrowth summary results from Moneta and BioCSL data
0.5Momenta-
AMomenta-
BMomenta-
C bio-CSL-1 bio-CSL-2 bio-CSL-3
% of cells containing 1 cell 77% 46% 35% 40% 46% 54% 48%% of cells containing more than 1
cell 23% 54% 65% 60% 54% 46% 52%Pr of clonality after 1 round 77% 46% 35% 40% 46% 54% 48%Pr of clonality after 2 rounds 95% 71% 58% 64% 71% 79% 73%Pr of clonality after 5 rounds 100% 95% 88% 92% 95% 98% 96%
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
FACS Sorting – the FDA view and new practices
“Implementation of plate imaging into our process immediately after cell sorting has yielded high resolution images of single cells. These images, together with those showing subsequent growth of a single colony are used to document that each final candidate clone is derived from a single cell progenitor”
Victor Cairns et al Sanofi (Framingham) Poster P1.69 ESACT meeting Barcelona 2015
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Regulatory requirements for FACS
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
History of the ClonePix
The original ClonePixFL concept was to enable the rapid screening of 10,000 clones in one stack of 10 plates. This requires plating at 1000 clones per plate or approximately 166 clones per well. The issue of monoclonality was not an IND requirement at this time
http://www.biopharma-reporter.com/Downstream-Processing/Genetix-launches-technology-for-biopharma-development
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
ClonePix and regulatory submissions
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Statistical evaluation of the ClonePix Method
• Method source - GEN tutorial – Using ClonePix FL to assess monoclonality, Nov 1, 2009
• http://www.genengnews.com/gen-articles/using-clonepix-fl-to-assess-monoclonality/3091/?kwrd=Multiplexing&page=1) • In a typical experiment, CHO cells are plated into semisolid medium to
produce 25 colony outgrowths per 35 mm diameter well (i.e., a six-well microplate well).
• At day 14, the colonies are around 0.75mm in diameter. • Using the formula (0.25 x π x (2d(c))2 x (n-1) / (0.25 x π x (2d(w))2)
• When colony number n=25, the diameter of the colony (d(c) ) = 0.75mm and the diameter of the well (d(w) ) = 35 mm, then the probability of coincidence is 4.4%
– Thus the probability of monoclonality for one round of cloning should be 95.6%.
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Statistical evaluation of the ClonePix method
• Quote from the GEN Article – “This experimental data “validates the statistical evaluation that
clonality after a single round of picking on the ClonePix FL system is >95.6% when picking larger-sized colonies (0.75mm diameter)”.
– “Using the same formula, it can be calculated that by picking at an earlier time point (when colonies are only 0.35 mm in diameter), the probability of monoclonality is increased to 99.0%. In addition, performing a second round of cloning (re-plating the picked clones and re-picking) increases the probability of monoclonality to 99.9%.”
• This data is relates to when there are 25 colonies per well
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Probability that colonies do not overlap
• “Probability of monoclonality is related to both the size and number of colonies in the well
• The formula published in GEN considers the “Probability of two colonies randomly overlapping and suggests a colony diameter between 0.35mm and 0.75mm may be optimal”
USFDA recommendation - “Data to support the clonality should include parameters used for colony selection”
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Probability colonies do not overlap
Colonies with diameter of 0.75mm Colonies with diameter of 0.35mm
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
ClonePix and monoclonality
• Reality
Data source : Sarah Kennett, PH.D. Review Chief Division of Monoclonal Antibodies, presentation at WCBP, Washington DC 2014
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Probability the pin does not touch the colony
Colonies with diameter of 0.75mm Colonies with diameter of 0.35mm
Picking pin
with 2.0 mm
diameter
Picking pin
with 2.0 mm
diameter
Picking pin
with 2.0 mm
diameter
Picking pin
with 2.0 mm
diameter
Picking pin
with 2.0 mm
diameter
Picking pin
with 2.0 mm
diameter
Colonies should be at least 1.2 mm apart
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
The probability to pick more than one colony
• Using the formula (0.25 x π x (d(c) + d(p))2 x (n-1) / (0.25 x π x (2d(w))2)
• d(p) = the outside diameter of the picking pin 2.0mm
This suggests that for an acceptable probability of monoclonality from ClonePix alone it is necessary to seed with a plating density of 25 cells per well or less
P(p) = Probability of only 1 colony picked
A significant contributor to the monoclonality estimate is the Probability that the pin only picks or
touches one colony
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
ClonePix and monoclonality
P(c) = P(o) x P(p) x P(sc)
P(c) = Probability of Clonality
P(o) = Probability colonies do not overlap
P(p) = Probability only 1 colony picked
P(sc) = Probability subsequent sub cloning step yields a single cell拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
ClonePix and adaptation from semi-solid media
• FDA guidance for adaptation
Data source : Sarah Kennett, PH.D. Review Chief Division of Monoclonal Antibodies, presentation at WCBP, Washington DC 2014
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
ClonePix and adaptation from semi-solid media
• Most, but not all users, in the US and Europe now use their ClonePix as a screening tool to remove poor producers / growers from a population rather than use it to identify and enrich ideal clones
• Why? – They have found limited correlation between growth characteristics in
semi-solid and those in liquid media – Often the high producing colonies in semi-solid media are not the high
producers when adapted to liquid media • Why?
– Forced adaptation to culture conditions can lead to drift in genotype and phenotype in a cell
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
The evolution of cell line cloning methods
• There are no “Approved” methods and you cannot “prove” monoclonality
Traditional
Statistical probability
Methods for generating the data
New
Statistical probability and photographic
evidence
Imaging systemsLimiting Dilution
ClonePix
FACS
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Imaging systems
• Current applications of imaging systems to improve cloning efficiency and probability of monoclonality – One round of limiting dilution in combination with an imaging
system has emerged as a popular alternative to the more traditional technique of two rounds of limiting dilution
– Similarly, FACS seeding in combination with an imaging system has been adopted by many large pharma in the US and Europe
– For the sub-cloning steps in the adaptation of colonies from semi-solid media to liquid media
– In combination with most other seeding methods are improved by combining them with an imaging system
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
From the regulatory perspective
• From the Sarah Kennett presentation at WCBP 2014
Data source : Sarah Kennett, PH.D. Review Chief Division of Monoclonal Antibodies, presentation at WCBP, Washington DC 2014
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Will all the cells be detected?
• Will all the cells be detected? – All imaging systems have a limited depth of focus so it is important
to ensure that all cells are on the bottom of the well to avoid the appearance of false negative / ghost colonies days after seeding
• Centrifugation is therefore proposed as the most reliable way of doing this.
– It is important that the efficiency of the centrifugation process is evaluated and the Probability of a cell being on the bottom of the well determined
– It is also important to determine the Probability that the imaging system will see a cell at the edge of the well
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Will all cells be detected?
• It is important to understand how the imaging system focuses on cells because although the cells are on the bottom of the well, the bottom of each well is at a different height in the plate
• This is a focus map of a commonly used microplate, there is a variance in height of almost 350µm across the plate
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Will all cells be detected?
• It is therefore important that the imaging system has a method of tracking and adjusting the focus on a well by well basis so that every well across the plate is always guaranteed to be in focus
• In practice, users that have imagers that do not employ well to well focus tracking report the loss of up to 10-20% of wells due to the inability to locate a cell on the day of seeding – Or put another way the Probability of monoclonality is significantly
diminished if all the cells cannot be imaged
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Imaging systems and probability of clonality
Probability of monoclonality P(c)
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Imaging systems and probability of clonality
P(m) = P(d) x P(p) x P(int)
Where P(m) = Probability method can see 1 cell at seeding P(d) = Probability imaging system can detect 1 cell P(p)= Probability cell is in a position that makes it detectable P(int) = Probability the image can be correctly interpreted by the user
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
The probability that imaging system can detect 1 cell is related to the image quality
Evenness of Illumination
Camera resolution (µm per pixel)
Data Compression
Depth of focus
Image Stitching
Focus
Contrast Monitor Resolution
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Imaging systems and probability of clonality
• Probability imaging system can detect 1 cell is related to image quality which is defined by: – Focus – Evenness of illumination – Contrast / dynamic range – Accuracy of positional relationship between well and
lens (image stitching) – Depth of focus / Numerical aperture – Data Compression – Resolution of monitor – Resolution of camera (optimum number of µm per
pixel) • 2µm per pixel is optimal for CHO cells • Note you can have too much resolution as well as not
enough resolution
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Imaging systems and probability of clonality
• Probability cell is detectable is defined by: – The cell being on the bottom of the well – Adapting to the changes in the position of the
well bottom across a microplate
• Probability the image is correctly interpreted by the user – Procedure requires more than 1 verifier – Ability to accurately locate any image
associated with a well at any time • Bar codes for correct plate id and orientation
• Integrated reporting to eliminate cut and paste errors拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Performance of imaging systems
• At the present time there is limited published data on the Probability of Monoclonality using an imaging system
• The data that is available suggests that if the correct methodology is applied then the Probability of Monoclonality is >99%
• The USFDA have in the past few weeks accepted an IND filing where the monoclonality probability has been determined using an imaging system
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Clone Screening – Data Collection
• Image microplates repeatedly over time • Confirm single cell arrival in the well • Confirm subsequent growth and division into a colony拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Clone Selection – Data Review
• Track backwards and review wells • Select those which are single cell origin拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Clone Selection – Data Review
• Highest quality image of single cell • Combination of 3 factors: Focus, Resolution, Contrast拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Image of the entire well needed
• Software demonstration
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Imaging system deliverables
• FDA requirements – Cells at edges of wells – Differentiate between 1 and 2 cells – Single colony not sufficient (single cell image needed) – Image of the entire well needed
• Additional information provided by imaging – What is in the plate before seeding – Images growth from single cell, to two cells, to small colony
onwards – Hard copy of images that are time stamped and cannot be edited – Image can be reviewed many people, at time of project, months
after project and years after project 拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Regulatory Considerations in Establishing Clonality for Cell lines expressing therapeutic proteins Audrey Jia, 5th Annual Cell Line Development & Engineering Asia, May 16-19 Shanghai, China
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
What happens if the cells move during the study?
1. The regulatory requirement is to show an image of a single cell, a whole well image and show that the system can differentiate between one and two cells
2. As part of the method validation it is necessary to determine the probability of there being only one cell in the well at time of seeding • This usually involves a statistical analysis of the number of ghost
colonies that appear • If on subsequent time points the cells move then this does
not affect the probability of monoclonality • The practical reality is that some cells do move and colonies
disperse in wells over time even if they have been derived from a single cell
• A well that contains a dispersed colony or more than one colony may still have been seeded with a single cell
• Viewing additional time points is a useful activity to help locate the position of a single cell that on day 0 and monitor colony growth. 拓
澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Formation of a single
colony (day 5-7)
Image of a single cell
on day 0
Image after doubling
(typically day 1)
Documentation to support regulatory filing
from only one round of sub-cloning,
irrespective of the seeding method
First round of Limiting dilution
FACS sorting
Post adaptation from semi solid
media
Day 7 - 14 Select clones of
interest based on colony
growth and track back to look
for single cells
Day 0 - Seed cells
Summary of the cloning process when using an imaging system
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Comparison of sub-cloning methods
Method Day 0 to 14 Day 15 to 28 Day 29 to 42Probability of
clonality
Limiting Dilution Round 1 Round 2 Statistical
FACS Seeding Statistical
Clonepix Round 1 Round 2
media
adaptation /
sub cloning
Statistical
Limiting Dilution &
ImagerRound 1 Evidence based,
typically >99%
FACS & Imager Seeding Evidence based,
typically >99%
ClonePix & Imager Round 1
media
adaptation /
sub cloning
Evidence based,
typically >99%拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Imagers open new possibilities
• The data here, courtesy of Arna Andrews of BioCSL, shows it is now possible to seed at densities of 1 cell / well and greater and improve cloning efficiency
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Setting new expectations
• If performed appropriately, a single round of cloning associated with imaging outperforms two rounds of LDC assessed via Coller & Coller statistics
Data source – The use of imaging to demonstrate clonality of production CHO Cell Lines – Experiences and learnings Presentation by Arna Andrews, Director, Cell Line Development, BioCSL Limited, Australia Informa Cell Line Development & Engineering Conference, April 11th 2016
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
Range of ProductsCell Metric Cell Metric CLD
Throughput Single plate Incubated 10 plate delivery system
Speed – Verify Clonality Mode (highest contrast)
4 – 5 min/plate Same as Cell Metric
Speed – Clone Growth Mode
3 - 4 min/plate Same as Cell Metric
Image quality Dynamic autofocus High contrast imaging Even illumination of entire well Optimal resolution
Same as Cell Metric
Metric Verify clonality Confluence (growth rates) Colony Counting option
Verify clonality Confluence (growth rates) Colony Counting option
GMP status IQ/OQ Documentation Package IQ/OQ Documentation Package
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
In conclusion
• From a regulatory perspective clonality is important in all stages of the process – Recommendation is that clonality to be established early in the product
development – USFDA now regard using an image as a “commonly used cloning method”
• Statistical methods may require re-evaluation now that it is possible to determine with a high probability if there is none, one or more cells in a well
• Imaging systems are compatible and improve most seeding methods in terms of workflow efficiency and quality of results
• Imaging systems deliver evidence which can be referred to at any time of the product lifecycle
• New, more efficient seeding methods may be possible拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]
拓澳生物
拓澳生物:www.topbiox.com 邮箱:[email protected]